Clinical Trials Sponsored by Imbioray (Hangzhou) Biomedicine Co., Ltd.

Total 505 results

Imbioray (Hangzhou) Biomedicine Co., Ltd.

Recruiting

Phase 1 Study of IBR854 in Locally Advanced Or Metastatic Solid Tumors

Solid Tumors

China
Wuxi People's Hospital
Imbioray (Hangzhou) Biomedicine Co., Ltd.

Recruiting

Study of Anti-5T4 CAR-NK Cell Therapy in Advanced Solid Tumors

Advanced Solid Tumors

China
Shanghai East Hospital
Imbioray (Hangzhou) Biomedicine Co., Ltd.

Recruiting

Study of Anti-5T4 CAR-raNK Cell Therapy in Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Solid Tumors

China
Wuxi People's Hospital
Imbioray (Hangzhou) Biomedicine Co., Ltd.

Recruiting

Study of Anti-CD33/CLL1 CAR-NK in Acute Myeloid Leukemia

Acute Myeloid Leukemia

China
Shandong Public Health Clinical Center
Imbioray (Hangzhou) Biomedicine Co., Ltd.

Not yet recruiting

IBR900 Cell Injection Combined With Lenvatinib or Bevacizumab in the Treatment of Advanced Primary Liver Cancer

Advanced Primary Liver Cancer
Imbioray (Hangzhou) Biomedicine Co., Ltd.
The First Affiliated Hospital of Soochow University

Not yet recruiting

Study of IBR733 Cell Injection in Acute Myeloid Leukemia

Acute Myeloid Leukemia

China
Jiangsu Sinorda Biomedicine Co., Ltd

Completed

Single-dose and Multiple-dose X842 Phase 1 Study

Healthy Volunteers

China
Jiangsu Sinorda Biomedicine Co., Ltd

Unknown

Study to Evaluate the Safety and Efficacy of X842 in Patients With Reflux Esophagitis

Reflux Esophagitis

China
BioRay Pharmaceutical Co., Ltd.

Not yet recruiting

A Phase I Study of BR115 for Injection Alone in Subjects With Advanced Solid Malignancies

Advanced Solid Malignancies

China
BioRay Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of BRY805 in Participants With Advanced Solid Tumors

Advanced Solid Tumor

China
BioRay Pharmaceutical Co., Ltd.

Not yet recruiting

Clinical Study of 1A46 Drug Substance

Advanced Malignancies

China
Hangzhou Converd Co., Ltd.

Recruiting

Safety of Recombinant Human IL-21 Oncolytic Vaccinia Virus Injection（hV01) in Advanced Tumors

Advanced Solid Tumors

China
HJB (Hangzhou) Co., Ltd.

Recruiting

TST002 Intervenous Injection in Postmenopausal Women and Men With Reduced Bone Mineral Density

Osteoporosis

China
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Jiangsu Aosaikang Biomedicine Co. LTD.

Recruiting

A 1/2 Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ASKB589 in Patients With Locally Advanced or Metastatic Solid Tumors

Malignant Solid Tumor

China
Hangzhou Valgen Medtech Co., Ltd

Not yet recruiting

Feasibility Study of the DragonFire for Hypertrophic Obstructive Cardiomyopathy

Obstructive Hypertrophic Cardiomyopathy

China
Kanglin Biotechnology (Hangzhou) Co., Ltd.

Not yet recruiting

A Phase I/II Clinical Study of the KL003 Cell Injection in β-Thalassemia Major Participants

Transfusion-dependent Beta-Thalassemia

China
Hangzhou GluBio Pharmaceutical Co., Ltd.

Recruiting

A Study of GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas

Non-Hodgkin Lymphoma

China
Westlake Pharmaceuticals (Hangzhou) Co., Ltd.

Recruiting

Phase III Clinical Study Evaluating the Efficacy and Safety of WPV01 in Patients With Mild/Moderate COVID-19

Mild to Moderate COVID-19

China
Hangzhou Sumgen Biotech Co., Ltd.

Recruiting

An Open-label Study of SG1827 in Subjects With Advanced Solid Tumors (CSG-1827-101)

Advanced Solid Tumors

China
Hangzhou Endonom Medtech Co., Ltd.

Recruiting

Guo's False Lumen Embolization : The First in Man Study of WeFlow-EndoSeal Aorta Vascular Plug System

Aortic Dissection Aneurysm

China
Hangzhou Endonom Medtech Co., Ltd.

Not yet recruiting

A Real World Study on Fabulous® Thoracic Aortic Stent System for Stanford B Aortic Dissection

Aortic Dissection

China
Hangzhou Sumgen Biotech Co., Ltd.

Recruiting

SG1906 for CLDN18.2-Positive Solid Tumors (CSG-1906-101)

Locally Advanced Unresectable or Metastatic Solid Tumors

China
Hangzhou Sciwind Biosciences Co., Ltd.

Recruiting

A Study To Evaluate the Safety of XW001 Inhalation in Children With RSV

RSV Infection

China
Hangzhou Highlightll Pharmaceutical Co., Ltd

Recruiting

The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis

Plaque Psoriasis

United States
Westlake Pharmaceuticals (Hangzhou) Co., Ltd.

Recruiting

Study of WPV01 Compared With Placebo in Patients With Mild/Moderate COVID-19 Infection

COVID-19 Infection

China
Hangzhou Endonom Medtech Co., Ltd.

Recruiting

Safety and Efficacy Study of WeFlow-JAAA Stent Graft System for Complex Abdominal Aortic Aneurysm(GREAT Study)

Juxtarenal Abdominal Aortic Aneurysm

China
Hangzhou Sumgen Biotech Co., Ltd.

Active, not recruiting

SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies

Relapsed or Refractory Multiple Myeloma | Hematological Malignancy

China
Hangzhou Adcoris Biopharmacy Co., Ltd

Enrolling by invitation

Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors

HER2-positive Advanced Solid Tumor

China
Hangzhou Sciwind Biosciences Co., Ltd.

Active, not recruiting

A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM

Type 2 Diabetes Mellitus | T2DM

China
Hangzhou Sciwind Biosciences Co., Ltd.

Active, not recruiting

A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity

Weight Management

China
Hangzhou Valgen Medtech Co., Ltd

Enrolling by invitation

Safety and Effectiveness Study of Dragonfly System for Degenerative Mitral Regurgitation

Degenerative Mitral Valve Disease

China
Hangzhou Broncus Medical Co., Ltd.

Completed

Safety and Effectiveness of Disposable Pulmonary Surgical Markers in the Localization of Pulmonary Nodules

Lung Cancer

China
Acea Bio (Hangzhou) Co., Ltd.

Unknown

Safety Study of FLP Injection to Treat Tumor Patients

Advanced Cancer

China
Hangzhou Highlightll Pharmaceutical Co., Ltd

Not yet recruiting

A Phase 3 Study of Efficacy and Safety of TLL-018 in CSU Participants With Inadequate Controll to Second Generation H1-antihistamines

Chronic Spontaneous Urticaria
Bliss Biopharmaceutical (Hangzhou) Co., Ltd

Recruiting

A First-in-human of Multiplle Doses of BB-1709 in Subjects With Locally Advanced/Metastatic Solid Tumors

Solid Tumor

China
Hangzhou Adcoris Biopharmacy Co., Ltd

Not yet recruiting

Study of ACR246 in Advanced Solid Tumors

Advanced Solid Tumors
Hangzhou DAC Biotechnology Co., Ltd.

Not yet recruiting

A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies

Advanced Solid Tumors | Hematological Malignancies
Hangzhou Sumgen Biotech Co., Ltd.

Recruiting

SG2918 For Advanced Malignant Tumors

Advanced Malignant Tumors

China
Hangzhou Sumgen Biotech Co., Ltd.

Recruiting

SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE)

China
Hangzhou Valgen Medtech Co., Ltd

Recruiting

Feasibility Study of the DragonFly-T System for Severe Tricuspid Regurgitation

Tricuspid Regurgitation

China
Hangzhou Valgen Medtech Co., Ltd

Not yet recruiting

Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation

Tricuspid Regurgitation

China
Bliss Biopharmaceutical (Hangzhou) Co., Ltd

Recruiting

A First-in-human of Multiplle Doses of BB-1705 in Subjects With Locally Advanced/Metastatic Solid Tumors

Solid Tumor

China
Hangzhou Endonom Medtech Co., Ltd.

Completed

Guo's Aortic Arch Reconstruction: The First in Man Study of WeFlow-Arch Modular Embedded Branch Stent Graft System

Aortic Arch; Aneurysm, Dissecting

China
Hangzhou Endonom Medtech Co., Ltd.

Active, not recruiting

Guo's Subclavian Artery Reconstruction: The Prospective, Multiple Center Study of WeFlow-Tbranch Stent Graft System(GUEST Study)

Type B Aortic Dissection

China
Hangzhou Highlightll Pharmaceutical Co., Ltd

Completed

Safety and Efficacy of TLL018 in Patients With Chronic Spontaneous Urticaria.

Chronic Spontaneous Urticaria

China
Hangzhou Valgen Medtech Co., Ltd

Active, not recruiting

Feasibility Study of the DragonFire for Hypertrophic Obstructive Cardiomyopathy

Obstructive Hypertrophic Cardiomyopathy

China
Westlake Pharmaceuticals (Hangzhou) Co., Ltd.

Completed

Study of WPV01 in Healthy Subjects

Healthy Participants

China
Hangzhou Highlightll Pharmaceutical Co., Ltd

Completed

Safety and Efficacy of TLL018 in Patients With Plaque Psoriasis

Moderate to Severe Plaque Psoriasis

China
Hangzhou Highlightll Pharmaceutical Co., Ltd

Completed

The Safety and Efficacy of TLL-018 in Active Rheumatoid Arthritis

Rheumatoid Arthritis

China
Hangzhou Sciwind Biosciences Co., Ltd.

Active, not recruiting

A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients

Type 2 Diabetes Mellitus | T2DM

China

Clinical Trials Sponsored by Imbioray (Hangzhou) Biomedicine Co., Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations